Estradiol and tamoxifen differentially regulate a plasmalemmal voltage-dependent anion channel involved in amyloid-beta induced neurotoxicity

Steroids

Volumn 76, Issue 9, 2011, Pages 840-844

  Herrera, Jose Luis ^a   Fernandez, Cecilia ^a   Diaz, Mario ^a   Cury, Debora ^a   Marin, Raquel ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

17 Estradiol; Amyloid beta; Estrogen receptor; Lipid rafts; Tamoxifen; Voltage dependent anion channel

Indexed keywords

AMYLOID BETA PROTEIN; CAVEOLIN 1; CYCLIC AMP DEPENDENT PROTEIN KINASE; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; G PROTEIN COUPLED RECEPTOR; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3BETA; LIPID; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN TYROSINE KINASE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; VOLTAGE DEPENDENT ANION CHANNEL;

ALZHEIMER DISEASE; APOPTOSIS; DEPHOSPHORYLATION; DRUG EFFECT; DRUG EXPOSURE; ENZYME ACTIVATION; FRONTAL LOBE; HIPPOCAMPUS; LIPID RAFT; MITOCHONDRION; NERVE CELL MEMBRANE; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARIETAL LOBE; PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ESTRADIOL; ESTROGENS; HUMANS; MEMBRANE MICRODOMAINS; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION; PROTEIN PHOSPHATASE 2; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SIGNAL TRANSDUCTION; TAMOXIFEN; VOLTAGE-DEPENDENT ANION CHANNELS;

EID: 79959890797     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2011.02.014     Document Type: Review

References (63)

1. Maggi A, Ciana P, Belcredito S, Vegeto E. Estrogens in the nervous system: mechanisms and nonreproductive functions. Ann Rev Physiol 2004;66:291-313. (Pubitemid 40626712)
2. Suzuki S, Brown CM, Wise PM. Mechanisms of neuroprotection by estrogen. Endocrine 2006;29:209-15. (Pubitemid 44097364)
3. Woolley CS. Acute effects of estrogen on neuronal physiology. Ann Rev Pharmacol Toxicol 2007;47:657-80.
4. Vasudevan N, Pfaff DW. Non-genomic actions of estrogens and their interaction with genomic actions in the brain. Front Neuroendocrinol 2008;29:238-57.
5. Marin R, Guerra B, Alonso R, Ramírez CM, Díaz M. Estrogen activates classical and alternative mechanisms to orchestrate neuroprotection. Curr Neurovasc Res 2005;4:287-301. (Pubitemid 41297367)
6. Correia SC, Santos RX, Cardoso S, Carvalho C, Santos MS, Oliveira CT, et al. Effects of estrogen in the brain: is it a neuroprotective agent in Alzheimer's disease? Curr Aging Sci 2010;3:113-26.
7. Sherwin BB, Henry JF. Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review. Front Neuroendocrinol 2008;29:88-113.
8. Kelly MJ, Rønnekleiv OK. Control of CNS neuronal excitability by estrogens via membrane-initiated signaling. Mol Cell Endocrinol 2009;308:17-25.
9. Brailiou E, Dun SL, Brailou GC, Mizou K, Sklar LA, Oprea TI, et al. Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system. J Endocrinol 2007;193:311-21.
10. Toran-Allerand CD, Guan X, MacLUsky NJ, Hovath TL, Diano S, Singh M, et al. ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and alter ischemic brain injury. J Neurosci 2002;22:8391-401. (Pubitemid 35387579)
11. Lebesgue D, Traub M, De Butte-Smith M, Chen C, Zukin RS, Kelly MJ, et al. Acute administration of non-classical estrogen receptor agonists attenuates ischemia-induced hippocampal neuron loss in middle-aged female rats. PLoS One 2010;5(1):e8642.
12. Toran-Allerand CD. Minireview: a plethora of estrogen receptors in the brain: where will it end? Endocrinology 2004;145:1069-74.
13. 1-40-induced toxicity in septal-derived cholinergic SN56 cells. J Neurochem 2003;85:1180-9.
14. Marin R, Ramirez CM, Gonzalez M, Alonso R, Diaz M. Alternative estrogen receptors homologous to classical receptor alpha in murine neural tissues. Neurosci Lett 2006;395:7-11. (Pubitemid 43175792)
15. Marin R, Ramirez CM, Gonzalez M, Gonzalez-Munoz E, Zorzano A, Camps M, et al. Voltage-dependent anion channel (VDAC) participates in amyloid betainduced toxicity and interacts with plasma membrane estrogen receptor alpha in septal and hippocampal neurons. Mol Membr Biol 2007;24:148-60. (Pubitemid 46633892)
16. Ramirez CM, Gonzalez M, Diaz M, Alonso R, Ferrer I, Santere G, et al. VDAC and ERα interaction in caveolae from human cortex is altered in Alzheimer's disease. Mol Cell Neurosci 2009;42:172-83.
17. Marin R, Ramirez CM, Morales A, Gonzalez M, Alonso R, Diaz M. Modulation of Aβ-induced neurotoxicity by estrogen receptor alpha and other associated proteins in lipid rafts. Steroids 2008;73:992-6.
18. Lingwood D, Simons K. Lipid rafts as a membrane-organizing principle. Science 2010;327:46-50.
19. Deecher DC, Swiggard P, Frain DE, O'Connor LT. Characterization of a membrane-associated estrogen receptor in a rat hypothalamic cell line (D12). Endocrine 2003;22:211-23.
20. Lisanti MP, Scherer PE, Tang Z, Sargiacomo M. Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis. Trends Cell Biol 1994;4:231-5. (Pubitemid 24190653)
21. Acconcia F, Ascenzi P, Bocedi A, Spisni E, Tomasi V, Trentalance A, et al. Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol. Mol Biol Cell 2005;16:231-7. (Pubitemid 40028339)
22. Marin R, Diaz M, Alonso R, Sanz A, Arévalo MA, Garcia-Segura LM. Role of estrogen receptor α in membrane-initiated signaling in neural cells: interaction with IGF-1 receptor. J Steroid Biochem Mol Biol 2009;114:2-7.
23. Marin R. Lipid rafts play a crucial role in protein interactions and intracellular signaling involved in neuronal preservation against Alzheimer's disease. In: Jelinek R, editor. Lipids and cellular membranes in amyloid diseases. Weinheim, Germany: Wiley-VCH Verlag; 2011. p. 159-69.
24. Bàthori G, Parolini I, Tombola F, Szabò I, Messina A, Oliva M, et al. Porin is present in the plasma membrane where it is concentrated in caveolae and caveolae-related domains. J Biol Chem 1999;274:29607-12.
25. Ehehalt R, Keller P, Haass C, Thiele C, Simons K. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol 2003;160:113-23. (Pubitemid 36091721)
26. Gaudreault SB, Dea D, Poirier J. Increased caveolin-1 expression in Alzheimer's disease brain. Neurobiol Aging 2004;25:753-9. (Pubitemid 38698250)
27. Michel V, Bakovic M. Lipid rafts in health and disease. Biol Cell 2007;99:129-40. (Pubitemid 46380925)
28. Boulware MI, Kordasiewicz H, Mermelstein PG. Caveolin proteins are essential for distinct effects of membrane estrogen receptors in neurons. J Neurosci 2007;27:9941-50. (Pubitemid 47403995)
29. Garcia-Segura LM, Cardona-Gomez GP, Chowen JA, Azcoitia I. Insulin-like growth factor-I receptors and estrogen receptors interact in the promotion of neuronal survival and neuroprotection. J Neurocytol 2000;29:425-37. (Pubitemid 32154525)
30. Garcia-Segura LM, Diz-Chaves Y, Perez-Martin M, Darnaudéry M. Estradiol, insulin-like growth factor-I and brain aging. Psychoneuroendocrinology 2007;32:S57-61.
31. Akanda N, Tofighi R, Brask J, Tamm C, Elinder F, Ceccatelli S. Voltage-dependent anion channels (VDAC) in the plasma membrane play a critical role in apoptosis in differentiated hippocampal neurons but not in neural stem cells. Cell Cycle 2008;7:3225-34.
32. Ferrer I. Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease. J Bioenergy Biomembr 2009;41:425-31.
33. Perez-Gracia E, Torrejon-Escribano B, Ferrer I. Dystrophic neuritis of senile plaques in Alzheimer's disease are deficient in cytochrome c oxidase. Acta Neuropathol 2008;116:261-8.
34. Herrera JL, Diaz M, Hernandez-Fernaud JR, Salido E, Alonso R, Fernandez C, et al. Voltage-dependent anion channel as a resident protein of lipid rafts: post-transductional regulation by estrogens and involvement in neuronal preservation against Alzheimer's disease. J Neurochem 2011, doi:10.1111/j.1471- 4159.2010.06987.
35. - channels by triphenylethylene antioestrogens in C1300 mouse neuroblastoma cells. J Physiol 2001;536:79-88.
36. Valverde MA, Hardy SP, Díaz M. Activation of Maxi Cl(-) channels by antiestrogens and phenothiazines in NIH3T3 fibroblasts. Steroids 2002;67:439-45. (Pubitemid 34311758)
37. Bahamonde MI, Fernández-Fernández JM, Guix FX, Vázquez E, Valverde MA. Plasma membrane voltage-dependent anion channel mediates antiestrogen-activated maxi Cl- currents in C1300 neuroblastoma cells. J Biol Chem 2003;35:33286-9.
38. Bera AK, Ghosh S. Dual mode of gating of voltage-dependent anion channel as revealed by phosphorylation. Struct Biol 2001;135:67-72.
39. Distler AM, Kerner J, Peterman SM, Hoppel CL. A targeted proteomic approach for the analysis of rat liver mitochondrial outer membrane proteins with extensive sequence coverage. Anal Biochem 2006;356:18-29. (Pubitemid 44232722)
40. Liberatori S, Canas B, Tani C, Bini L, Buonocore G, Godovac-Zimmermann J, et al. Proteomic approach to the identification of voltage-dependent anion channel protein isoforms in guinea pig brain synaptosomes. Proteomics 2004;4:1335-40. (Pubitemid 38648021)
41. Dhandapani KM, Brann DW. Protective effects of estrogen and selective estrogen receptor modulators in the brain. Biol Reprod 2002;67:1379-85. (Pubitemid 35204912)
42. O'Neill K, Chen S, Brinton RD. Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer's disease. Exp Neurol 2004;185:63-80. (Pubitemid 38010279)
43. Benvenuti S, Luciani P, Vannelli GB, Gelmini S, Franceschi E, Serio M, et al. Estrogen and selective estrogen receptor modulators exert neuroprotective effects and stimulate the expression of selective Alzheimer's disease indicator-1, a recently discovered antiapoptotic gene, in human neuroblast long-term cell cultures. J Clin Endocrinol Metab 2005;90:1775-82. (Pubitemid 40464051)
44. Biewenga E, Cabell L, Audesirk T. Estradiol and raloxifene protect cultured SN4741 neurons against oxidative stress. Neurosci Lett 2005;373:179-83. (Pubitemid 41556554)
45. Hashimoto M, Inoue S, Muramatsu M, Masliah E. Estrogens stimulate tamoxifen-induced neuronal cell apoptosis in vitro: a possible nongenomic action. Biochem Biophys Res Commun 1997;240:464-70. (Pubitemid 127742239)
46. Ellerby HM, Martin SJ, Ellerby LM, Naiem SS, Rabizadeh S, Salvesen GS, et al. Establishment of a cell-free system of neuronal apoptosis: comparison of premitochondrial, mitochondrial, and postmitochondrial phases. J Neurosci 1997;17:6165-78. (Pubitemid 27329892)
47. Hoyt KR, McLaughlin BA, Higgins Jr DS, Reynolds IJ. Inhibition of glutamate-induced mitochondrial depolarization by tamoxifen in cultured neurons. J Pharmacol Exp Ther 2000;293:480-6. (Pubitemid 30244097)
48. Diaz M, Marrero-Alonso J, Garcia-Marrero B, Marin R, Gomez T, Alonso R. Cellular and molecular basis for acute nongenomically mediated actions of SERMs. In: Cano A, Calaf i Alsina J, Dueñas-Diez JL, editors. Selective estrogen receptor modulators. Heidelberg, Berlin: Springer Verlag; 2006. p. 79-102.
49. Diaz M. Triphenylethylene antiestrogen-induced acute relaxation of mouse duodenal muscle. Possible involvement of calcium channels. Eur J Pharmacol 2002;445:257-66. (Pubitemid 34655683)
50. Marrero-Alonso J, García Marrero B, Gómez T, Diaz M. Functional inhibition of intestinal and uterine muscles by non-permeant triphenylethylene derivatives. Eur J Pharmacol 2006;532:115-27.
51. Raz L, Khan MM, Mahesh VB, Vadlamudi RK, Brann DW. Rapid estrogen signaling in the brain. Neurosignals 2008;16:140-53. (Pubitemid 351263221)
52. Bi R, Broutman G, Foy MR, Thompson RF, Baudry M. The tyrosine kinase and mitogen-activated protein kinase pathways mediate multiple effects of estrogen in hippocampus. Proc Natl Acad Sci U S A 2000;97:3602-7. (Pubitemid 30183349)
53. Fitzpatrick JL, Mize AL, Wade CB, Harris JA, Shapiro RA, Dorsa DM. Estrogen-mediated neuroprotection against β-amyloid toxicity requires expression of estrogen receptor α or β and activation of the MAPK pathway. J Neurochem 2002;82:674-82. (Pubitemid 34831505)
54. Guerra B, Díaz M, Alonso R, Marin R. Plasma membrane oestrogen receptor mediates neuroprotection against β-amyloid toxicity through activation of Raf-1/MEK/ERK cascade in septal-derived cholinergic SN56 cells. J Neurochem 2004;91:99-109. (Pubitemid 39314941)
55. Bryant DN, Sheldahl LC, Marriot LK, Shapiro RA, Dorsa DM. Multiple pathways transmit neuroprotective effects of gonadal steroids. Endocrine 2006;29:199-207. (Pubitemid 44097363)
56. Szego{combining double acute accent} EM, Csorba A, Janáky T, Kékesi KA, Abrahám IM, Mórotz GM, et al. Effects of estrogen on beta-amyloid-induced cholinergic cell death in the nucleus basalis magnocellularis. Neuroendocrinology 2010, doi:10.1159/000321119.
57. Zhang L, Rubinow DR, Xaing G, Li BS, Chang YH, Maric D, et al. Estrogen protects against beta-amyloid-induced neurotoxicity in rat hippocampal neurons by activation of Akt. Neuroreport 2001;12:1919-23. (Pubitemid 32553708)
58. Zhao L, Yao J, Mao Z, Cheng S, Wang Y, Brinton RD. 17beta-estradiol regulates insulin-degrading enzyme expression via an ERbeta/PI3-K pathway in hippocampus: relevance to Alzheimer's prevention. Neurobiol Aging 2010, doi:10.1016/j.neurobiolaging.2009.12.010.
59. Jover-Mengual T, Miyawaki T, Latuszek A, Alborch E, Zukin RS, Etgen AM. Acute estradiol protects CA1 neurons from ischemia-induced apoptotic cell death via the PI3K/Akt pathway. Brain Res 2010;1321:1-12.
60. Takashima A. GSK-3 is essential in the pathogenesis of Alzheimer's disease. J Alzheimers Dis 2006;9:309-17. (Pubitemid 44253325)
61. Goodenough S, Schleusner D, Pietrzik C, Skutella T, Behl C. Glycogen synthase kinase 3β links neuroprotection by 17β-estradiol to key Alzheimer processes. Neuroscience 2005;132:581-9.
62. Yoo BC, Fountoulakis M, Cairns N, Lubec G. Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down Syndrome. Electrophoresis 2001;22:172-9.
63. Martin V, Fabelo N, Santpere G, Puig B, Marin R, Ferrer I, et al. Lipid alterations in lipid rafts from Alzheimer's disease human brain cortex. J Alzheimer's Dis 2010;19:489-502.